Citation Impact
Citing Papers
Species Interactions in a Parasite Community Drive Infection Risk in a Wildlife Population
2010 StandoutScience
mRNA mediates passive vaccination against infectious agents, toxins, and tumors
2017
How mRNA therapeutics are entering the monoclonal antibody field
2019
A method to identify respiratory virus infections in clinical samples using next-generation sequencing
2019
Reducing cell intrinsic immunity to mRNA vaccine alters adaptive immune responses in mice
2023 StandoutNobel
ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform
2004 Standout
Passive immunotherapy of viral infections: 'super-antibodies' enter the fray
2018
Analysis of the cytokine profile in spleen cells from dogs naturally infected by Leishmania chagasi
2006
Messenger RNA-Based Vaccines Against Infectious Diseases
2020 StandoutNobel
mRNA as novel technology for passive immunotherapy
2018
Leishmaniasis
2018 Standout
Testicular Germ-Cell Cancer
1997 Standout
Neglected tropical diseases
2009 Standout
Monocyte recruitment during infection and inflammation
2011 Standout
Opportunities for therapeutic antibodies directed at G-protein-coupled receptors
2017
Diagnosis of canine visceral leishmaniasis: Biotechnological advances
2006
A Membrane Topology Model for Human Interferon Inducible Transmembrane Protein 1
2014
Parasite interactions in natural populations: insights from longitudinal data
2008
Common roots: a contextual review of HIV epidemics in black men who have sex with men across the African diaspora
2012
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
2007 Standout
Canine leishmaniosis – new concepts and insights on an expanding zoonosis: part one
2008 Standout
Lipid nanoparticles for mRNA delivery
2021 Standout
Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site.
1995
PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake
2018 StandoutNobel
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
The Neglected Tropical Diseases of Latin America and the Caribbean: A Review of Disease Burden and Distribution and a Roadmap for Control and Elimination
2008 Standout
Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
2021 StandoutNobel
COVID-19: A promising cure for the global panic
2020 Standout
Cutaneous leishmaniasis
2007 Standout
Exploitation of glycosylation in enveloped virus pathobiology
2019
Induction of mucosal and systemic antibody responses against the HIV coreceptor CCR5 upon intramuscular immunization and aerosol delivery of a virus-like particle based vaccine
2009
Reshaping human antibodies for therapy
1988 StandoutNatureNobel
Antiviral resistance of stem cells
2018 StandoutNobel
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
2014 Standout
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Epidemiology of Visceral Leishmaniasis in Northeast Brazil
1992
Intramuscular Delivery of Replicon RNA Encoding ZIKV-117 Human Monoclonal Antibody Protects against Zika Virus Infection
2020
Diagnostic and therapeutic management of cancer of an unknown primary
2003
Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice
2020
A molecular signature of metastasis in primary solid tumors
2002 Standout
Intrinsic Immunity Shapes Viral Resistance of Stem Cells
2017 StandoutNobel
Assessing the Privacy Risks of Data Sharing in Genomics
2010
Treatment of Patients with Cancer of an Unknown Primary Site
1993
Direct Visualization by Cryo-EM of the Mycobacterial Capsular Layer: A Labile Structure Containing ESX-1-Secreted Proteins
2010
The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity
2008
IgG subclass responses in a longitudinal study of canine visceral leishmaniasis
2003
Global epidemiology of HIV infection in men who have sex with men
2012 Standout
Applications of CRISPR technologies in research and beyond
2016 StandoutNobel
Revolutionizing healthcare: the role of artificial intelligence in clinical practice
2023 Standout
Anti-Inflammatory Drugs Block Cytokine mRNA Accumulation in the Skin and Improve the Clinical Condition of Reactional Leprosy Patients
2000
MicroRNA expression profiles classify human cancers
2005 StandoutNatureNobel
The Association Between a Darc Gene Polymorphism and Clinical Outcomes in African American Patients With Acute Lung Injury
2011
Serodiagnosis of Leishmaniasis
1995
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration
2021 StandoutNobel
IgG1 as a Potential Biomarker of Post-chemotherapeutic Relapse in Visceral Leishmaniasis, and Adaptation to a Rapid Diagnostic Test
2014
The acute respiratory distress syndrome
2012 Standout
Anti-leishmanial IgE antibodies: a marker of active disease in visceral leishmaniasis.
1998
Evaluation of a newly developed direct agglutination test (DAT) for serodiagnosis and sero-epidemiological studies of visceral leishmaniasis: comparison with IFAT and ELISA
1987
Probing the Mycobacterial Trehalome with Bioorthogonal Chemistry
2012 StandoutNobel
Neutrophil recruitment and function in health and inflammation
2013 Standout
Mining electronic health records: towards better research applications and clinical care
2012 Standout
IFITM3 directly engages and shuttles incoming virus particles to lysosomes
2018 StandoutNobel
Leishmaniasis
1999 Standout
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Nanomaterial Delivery Systems for mRNA Vaccines
2021 StandoutNobel
Reshaping Human Antibodies: Grafting an Antilysozyme Activity
1988 StandoutScienceNobel
IFITM-Family Proteins: The Cell's First Line of Antiviral Defense
2014
False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?
2006
Pancreatic cancer: epidemiology, genetics, and approaches to screening.
2002
The relationship between blood groups and disease
2010
Meta-analysis: New Tests for the Diagnosis of Latent Tuberculosis Infection: Areas of Uncertainty and Recommendations for Research
2007 Standout
Interferon-Induced Transmembrane Protein 1 Restricts Replication of Viruses That Enter Cells via the Plasma Membrane
2018
Therapeutic Glucocorticoid-Induced TNF Receptor-Mediated Amplification of CD4+ T Cell Responses Enhances Antiparasitic Immunity
2010 StandoutNobel
Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?
2019 Standout
Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures
2007 Standout
Advances in leishmaniasis
2005 Standout
Osmosensory signaling in Mycobacterium tuberculosis mediated by a eukaryotic-like Ser/Thr protein kinase
2013 StandoutNobel
Drug repurposing for viral cancers: A paradigm of machine learning, deep learning, and virtual screening‐based approaches
2023
Leish-KIT, a stable direct agglutination test based on freeze-dried antigen for serodiagnosis of visceral leishmaniasis
1995
Point-of-Care Diagnostics for Global Health
2008 Standout
Next biotech plants: new traits, crops, developers and technologies for addressing global challenges
2015
Preterm labor: One syndrome, many causes
2014 StandoutScience
Progress with induction of HIV broadly neutralizing antibodies in the Duke Consortia for HIV/AIDS Vaccine Development
2023 StandoutNobel
A simple and economical direct agglutination test for serodiagnosis and sero-epidemiological studies of visceral leishmaniasis
1986
Cloning immunoglobulin variable domains for expression by the polymerase chain reaction.
1989 StandoutNobel
Regulation of the Trafficking and Antiviral Activity of IFITM3 by Post-Translational Modifications
2014
Human lymphocyte Hybridomas and Monoclonal Antibodies
1986
The Continuing Challenges of Leprosy
2006 Standout
Role of the cellular protein hDaxx in human cytomegalovirus immediate-early gene expression
2006
Works of Edward Wright being referenced
Development of broad‐spectrum human monoclonal antibodies for rabies post‐exposure prophylaxis
2016
Planning for the unexpected: Ebola virus, Zika virus, what's next?
2016
Monoclonal antibodies for prophylactic and therapeutic use against viral infections
2013
Epstein Barr Virus Associated Lymphomas and Epithelia Cancers in Humans
2020
Mycobacterium avium rough-to-smooth colony conversion resulting from growth in Tween 80 without presence of type-specific glycopeptidolipid antigens
1992
Minimal In Vivo Efficacy of Iminosugars in a Lethal Ebola Virus Guinea Pig Model
2016
Poorly differentiated carcinoma of unknown primary site: clinical usefulness of immunoperoxidase staining.
1991
Skin test responsiveness to a series of new tuberculins of children living in three Vietnamese cities
1989
Duffy Antigen Receptor for Chemokines Mediates trans-Infection of HIV-1 from Red Blood Cells to Target Cells and Affects HIV-AIDS Susceptibility
2008
HIV blocking antibodies following immunisation with chimaeric peptides coding a short N-terminal sequence of the CCR5 receptor
2008
Changes in cellular response to mycobacterial antigens and cytokine production patterns in leprosy patients during multiple drug therapy
1998
Ets-2 repressor factor recruits histone deacetylase to silence human cytomegalovirus immediate-early gene expression in non-permissive cells
2005
Association between active GB virus-C (hepatitis G) infection and HIV-1 disease in Uganda
2007
Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparison
2008
Serodiagnosis of Sudanese visceral and mucosal leishmaniasis: comparison of ELISA-immunofluorescence and indirect haemagglutination
1986
Chicken Interferon-Inducible Transmembrane Protein 3 Restricts Influenza Viruses and Lyssaviruses In Vitro
2013
Poorly differentiated carcinoma of unknown primary site: correlation of light microscopic findings with response to cisplatin-based combination chemotherapy.
1987
Production, characterization, and antigen specificity of recombinant 62‐71‐3, a candidate monoclonal antibody for rabies prophylaxis in humans
2013
ELISA using intact promastigotes for immunodiagnosis of kala-azar
1985
Increase of hybridoma formation by human lymphocytes after stimulation in vitro; effect of antigen, endothelial cells, and PWM.
1982
Characterization of the humoral immune response in Sudanese leishmaniasis: specific antibody detected by class- and subclass-specific reagents.
1986
Bat and pig IFN-induced transmembrane protein 3 restrict cell entry by influenza virus and lyssaviruses
2015